Clinical Trials Directory

Trials / Completed

CompletedNCT05829785

Influence of Obesity on Microvascular Reactivity During General Anesthesia

Status
Completed
Phase
Study type
Observational
Enrollment
128 (actual)
Sponsor
Pusan National University Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study was to investigate the effect of obesity on changes in microvascular reactivity and tissue oxygen saturation (StO2) during general anesthesia using near-infrared spectroscopy in conjunction with vascular occlusion tests (VOT). For this prospective observation investigation, a total of 128 patients who underwent elective surgery under general anesthesia at Pusan National University Hospital between June 2018 and February 2021 were participated in this study. Baseline StO2 on thenar eminence, hemodynamics, and laboratory profile were monitored before (Tpre) and 30 min after general anesthesia (Tpost). During vascular occlusion tests (VOT), the occlusion slope representing oxygen consumption of muscle and recovery slope representing microvascular reactivity were also collected at Tpre and Tpost. For analysis, the patients were divided into two groups: overweight (body mass index \[BMI\] ≥ 25 kg/m2) and normal weight (BMI \< 25).

Detailed description

Preoperative laboratory findings were obtained. Mean blood pressure (MBP), pulse oxygen saturation (SpO2), heart rate (HR), skin temperature, and VOT-derived measurements, including baseline tissue oxygen saturation (StO2), occlusion slope, minimum StO2, time to minimum StO2, recovery slope, maximum StO2, and time to baseline StO2 were recorded before (Tpre) and 30 min after general anesthesia (Tpost).

Conditions

Interventions

TypeNameDescription
DEVICENear-infrared spectroscopy monitortissue oxygen saturation monitoring combined with vascular occlusion test

Timeline

Start date
2018-06-01
Primary completion
2021-02-28
Completion
2021-02-28
First posted
2023-04-26
Last updated
2023-10-17

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT05829785. Inclusion in this directory is not an endorsement.